Type 2 & other diabetes

Updating a Clinical Prediction Model for Identifying Monogenic Diabetes to Include Both Clinical Features and Biomarkers

Diabetes CarePublished Prediction model development and external validation study

Authors' conclusion

We developed an updated monogenic diabetes probability calculator that integrates both clinical features and biomarkers, providing greater discrimination than using clinical features or biomarkers alone and providing appropriate measures for selecting individuals for monogenic diabetes diagnostic testing. This is now available as an online calculator and has immediate clinical utility for White European individuals diagnosed with diabetes ≤35 years.

Study context

Population
Individuals with diabetes; early-insulin-treated (proxy for T1D) and not-early-insulin-treated (proxy for T2D); case-control data (monogenic diabetes = 594, non-monogenic diabetes = 597), UNITED population data, external validation cohortUNITED population data 1,299 · external validation cohort 1,025
Comparison
Clinical features + biomarkers model vs clinical features only vs biomarkers alone
Outcome
Discrimination (ROCAUC) for monogenic diabetes
Methodological detailsBayesian recalibration mixture model, case-control development, recalibrated to population data, external validation in independent population-based cohort
  • Bayesian recalibration mixture model
  • Case-control development
  • Recalibrated to population data
  • External validation in independent population-based cohort

Performance

As reported in the abstract

ROCAUC, early-insulin-treated individuals

Clinical features + biomarkers

0.98

95% CrI 0.95–0.98

Clinical features only

0.80

95% CrI 0.71–0.82

Biomarkers alone

0.96

95% CrI 0.95–0.97

P < 0.001

Further findings

ROCAUC, not-early-insulin-treated participants

ROCAUC
0.86 (95% CrI 0.85-0.88)

External validation ROCAUC

Early-insulin-treated
0.98 (95% CrI 0.98-0.98)
Not-early-insulin-treated
0.92 (95% CrI 0.90-0.93)
Both models calibrated well

Positive test rate for monogenic diabetes using ≥5% probability threshold

Positive test rates
16-19%

Original publication

Updating a Clinical Prediction Model for Identifying Monogenic Diabetes to Include Both Clinical Features and Biomarkers. Diabetes Care. Published 14 October 2025. doi:10.2337/dc25-1029

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.